Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;49(9):1334-1343.
doi: 10.1002/eji.201948156. Epub 2019 Aug 12.

Biologicals targeting type 2 immunity: Lessons learned from asthma, chronic urticaria and atopic dermatitis

Lorenzo Cosmi  1   2 , Laura Maggi  1 , Alessio Mazzoni  1 , Francesco Liotta  1   2 , Francesco Annunziato  1
Affiliations
Free article
Review

Biologicals targeting type 2 immunity: Lessons learned from asthma, chronic urticaria and atopic dermatitis

Lorenzo Cosmi et al. Eur J Immunol. 2019 Sep.
Free article

Abstract

During the last decades, progression of research has led to great achievements for treatment and therapy of several disabling disorders, particularly in the field of chronic inflammatory diseases. The increased knowledge of the molecular mechanisms operating in such diseases has represented the first step in this process, and the discovery of molecules able to interfere with the natural history of the diseases, has been the second. This review is focused on the effects of biologics on type 2 diseases such as asthma, chronic urticaria and atopic dermatitis, both biologics just approved for clinical application and also those that are currently undergoing clinical trials. We will also discuss aspects and emphasize clinical trials and recently published studies, as well as research that is currently in the progress, which will be highly relevant for basic immunologists. Likewise, we will cover aspects that are pertinent for clinical immunologists and highlight translational studies that are evaluating novel biologicals in animal models.

Keywords: atopic dermatitis; bronchial asthma; chronic urticaria; precision medicine.

PubMed Disclaimer

References

    1. Canonica, G. W., Ferrando, M., Baiardini, I., Puggioni, F., Racca, F., Passalacqua, G. and Heffler, E., Asthma: personalized and precision medicine. Curr. Opin. Allergy Clin. Immunol. 2018. 18: 51-58.
    1. Kerr, W. G. and Chisholm, J. D., The next generation of immunotherapy for cancer: small molecules could make big waves. J. Immunol. 2019. 202: 11-19.
    1. Cosmi, L., Maggi, L., Santarlasci, V., Liotta, F. and Annunziato, F., T helper cells plasticity in inflammation. Cytometry A 2014. 85: 36-42.
    1. Parronchi, P., De Carli, M., Manetti, R., Simonelli, C., Sampognaro, S., Piccinni, M. P., Macchia, D. et al., IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 1992. 149: 2977-2983.
    1. Annunziato, F. and Romagnani, C., Romagnani S The 3 major types of innate and adaptive cell-mediated effector immunity. J. Allergy Clin. Immunol. 2015. 135: 626-635.

Publication types

Substances